For newly diagnosed GBM, autologous vaccination with tumor lysate-pulsed DC enhanced the precursor frequency of CD4+ T and CD4+ interferon (IFN) γ-producing cells, suggesting an induced tumor-specific CTL response [76]. This evidence concerns the gene CD4 and neoplasm.